The error-free reproducibility in results offered by automated liquid handling systems is a significant advantage, which is essential when it comes to drug discovery, disease and diagnostics research in pharmaceutical and clinical settings.

According to a new report published by Allied Market Research, titled, "Automated Liquid Handling (ALH) Market by Type, Modality, Procedure, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global ALH market was valued at $585 million in 2016, and is projected to reach $1,054 million by 2023, growing at a CAGR of 8.7% from 2017 to 2023. The multi-instrument ALH system segment is anticipated to witness highest growth rate from 2017 to 2023.

The major companies profiled in the report include Tecan Group Ltd., Corning Incorporated, Hamilton Company, Agilent Technologies, Mettler-Toledo International Inc., PerkinElmer Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Aurora Biomed, and Eppendorf AG.

Download Sample PDF Brochure at:

Automated liquid handling (ALH) has now become a vital tool in drug development and discovery, especially in high-throughput screening procedures comprising millions of compounds. Different innovations in ALH systems have facilitated assay miniaturization, thereby exponentially accelerating the discovery of chemical probes and drug candidates for querying biological systems.

The major factors that drive the global ALH market are advantages of ALH systems over manual pipetting, dearth in skilled professionals, and technological advancements associated with ALH systems. In addition, rise in awareness of the benefits of using ALH is expected to fuel the market growth. However, high costs of instruments and complex operability of advanced ALH systems are expected to restrain the market growth.

Furthermore, untapped potential of emerging markets provides lucrative opportunities to the market players.

The standalone ALH type segment occupied the highest share in ALH type market in 2016, owing to their sheer usage and availability in different research and clinical settings. The ALH PCR setup procedure segment witnessed the highest growth rate in 2016. However, the serial dilution procedure is anticipated to dominate the market.

At present, the biotechnology and pharmaceutical companies dominate the end user segment, and are expected to grow at a CAGR of 7.5% during the forecast period. This is attributable to increase in usage and application of ALH systems to carry out high-throughput screening in these companies.

Do Purchase Enquiry at:

Author's Bio: 

I am Satyajit Shinde. My keen interest in reading and writing. I forayed into the field of writing due to my love for words and the urge to do something different. I have been a part of the content resource team here in Allied Market Research. We have a dedicated team for content development wherein, we coordinate with the Market Analysts and create a precise content. I am personally involved in writing content for user engagement. I owe a responsibility to make sure the content is rich and user-centric. Allied Market Research has given me the chance to gain knowledge about different subjects.